Ranking Profile - Coherus BioSciences Inc

Introduction

Coherus BioSciences Inc (Coherus) is a biopharmaceutical company that conducts research, development and commercialization of immunotherapies to treat cancer. The company markets Udenyca (pegfilgrastim-cbqv), a biosimilar of Neulasta, and Cimerli (ranibizumab-eqrn), a biosimilar of Lucentis, in the US. Coherus products find its application for the treatment of various therapeutic areas which includes nasopharyngeal carcinoma, hepatocellular carcinoma, non-small lung cancer, small cell lung cancer and solid tumors. It is evaluating Toripalimab’s pivotal clinical trial for the treatment of nasopharyngeal carcinoma. The company also plans to launch Humira, a biosimilar Yusimry (adalimumab-aqvh) in the current fiscal year. It collaborates with other organizations to develop drug candidates. Coherus is headquartered in Redwood City, California, the US.